Crossmark

Rationale and evidence on the use of tocilizumab in COVID-19: A systematic review. Authors’ reply

Crossref DOI link: https://doi.org/10.1016/j.pulmoe.2020.10.003

Published Online: 2025-03-10

Published Print: 2021-01-30

Update policy: https://doi.org/10.1080/tandf_crossmark_01

Authors

Cortegiani, A.

Ippolito, M.

Einav, S.
License Information

Version of Record valid from 2021-01-30
More Information

Peer Review Statement: The publishing and review policy for this title is described in its Aims & Scope.

Aim & Scope: http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=tpul20

Publication History

Received: 2020-10-08

Published: 2025-03-10